Baylor researchers use a faster, more cost-effective technology to discover SARS-CoV-2 inhibitor

By | September 1, 2021
Much progress has been made on the development of vaccines aiming at triggering human immunity to SARS-CoV-2, the virus that causes COVID-19. In addition, researchers at Baylor College of Medicine are involved in the development of antiviral drugs to treat infected individuals.